ArticleBMC pediatrics2026
Hypertension in middle childhood.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHypertension is increasingly recognized among children. The etiology and presentation depend crucially on the child’s age. In infancy, secondary causes clearly predominate; however, this is less the case as the child grows. Our study aimed to evaluate children with hypertension aged 6 to 11 years, where secondary causes are not as frequent as in younger age, and primary/obesity-related hypertension is not as pronounced as in adolescence.
methodsWe retrospectively analyzed data from 784 children with consistently elevated blood pressure confirmed by ambulatory blood pressure monitoring. Among these, we analyzed the frequency of hypertension presence and etiology in children aged 6 to 11 years, along with anthropometric measures, target organ damage, and laboratory results.
results22.2% of children with hypertension belonged to the group of children aged from 6 to 11 years. A total of 167 children were analyzed retrospectively. In 18%, the cause was at least possibly secondary, most commonly of renal etiology, where a straightforward association can not be confirmed or excluded. In primary hypertension, excess weight was frequent, with 76.7% overweight, which significantly affected clinical presentation. Liver steatosis and left ventricular hypertrophy were more common in children with obesity-related primary hypertension (p < 0.001 for both variables).
conclusionsThe occurrence of hypertension between 6 and 11 years is mostly due to essential hypertension, and overweight is the most critical risk factor. Target organ damage is significantly associated with being overweight rather than having hypertension, which exacerbates cardiovascular risk in middle childhood. Some comorbidities associated with obesity are less pronounced in middle childhood than in adolescence, providing an early opportunity to implement preventive measures. In middle childhood, cases of secondary hypertension are rare but not uncommon. Especially, children with kidney disease are at increased risk for the development of hypertension and should be screened.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.